Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Capital Reinvestment Ratio

Latest as of September 2025: 2.35x

Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Capital Reinvestment Ratio of 2.35x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥18.31 Million) in capital expenditures (CN¥43.04 Million). Check Jiangxi Fushine Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.35x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥18.31 Million
CNY

Capital Expenditures

CN¥43.04 Million
CNY

Data as of

Sep 2025
Most recent filing

Jiangxi Fushine Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Jiangxi Fushine Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 300497 cash generation efficiency.

Annual Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. See how much free cash does Jiangxi Fushine Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 3.59x CN¥62.67 Million CN¥224.88 Million ▲ +375.0%
2024 0.76x CN¥187.64 Million CN¥141.75 Million ▼ -92.0%
2021 9.40x CN¥72.32 Million CN¥679.60 Million ▲ +699.8%
2020 1.17x CN¥382.35 Million CN¥449.24 Million ▲ +22.2%
2019 0.96x CN¥337.91 Million CN¥324.90 Million ▲ +3.2%
2018 0.93x CN¥175.91 Million CN¥163.89 Million ▲ +98.3%
2017 0.47x CN¥210.72 Million CN¥98.99 Million ▲ +8.9%
2016 0.43x CN¥188.53 Million CN¥81.34 Million ▼ -56.7%
2015 1.00x CN¥74.01 Million CN¥73.74 Million ▼ -39.7%
2014 1.65x CN¥31.39 Million CN¥51.86 Million ▲ +25.0%
2013 1.32x CN¥57.22 Million CN¥75.60 Million ▲ +62.9%
2012 0.81x CN¥63.20 Million CN¥51.24 Million ▼ -66.7%
2011 2.43x CN¥33.80 Million CN¥82.21 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow